Technical Forum: Small-Molecule Synthesis - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Technical Forum: Small-Molecule Synthesis
Pharmaceutical Technology gains insight into approaches for producing aromatic amines.


Pharmaceutical Technology
Volume 34, Issue 9, pp. 48-50

References

1. R.N. Salvatore, C. H. Yoon, and K.W. Jung, Tetrahedron 57 (10) 7785–7811 (2001).

2. Y. Watanabe et al., Tetrahedron Lett. 22 (28), 2667–2670 (1981).

3. Y. Watanabe et al., J. Org. Chem. 49 (18), 3359–3363 (1984).

4. Y. Watanabe et al., J. Org. Chem. 61 (13), 4214–4218 (1996).

5. C. Jun et al., Chem. Commun. 13, 1405–1406 (1998).

6. R.A.T.M. Abbenhuis, J. Boersma, and G. van Koten, J. Org. Chem. 63 (13), 4282–4290 (1998).

7 T. Naota, H. Takaya, and S.I. Murahashi, Chem. Rev. 98 (7), 2599–2660 (1998).

8. R. Grigg et al. J. Chem. Soc. Chem. Commun. 12, 611–612 (1981).

9. G. Cami Kobeci, and J.M. Williams. J. Chem. Soc. Commun., 1072–1073 (2004).

10. K.I. Fujita and R. Yamaguchi, Synlett. 4, 560–571 (2005).

11. R. Yamaguchi et al., Org. Lett. 10 (2) 181–184 (2008).

12. D. Hollmann et al., Angew. Chem. Int. Ed. 46 (43), 8291–8294 (2007).

13. A. Tillack et al., Tetrahedron Lett. 47 (50), 8881–8885 (2006).

14. K. Fujita, Y. Enoki, and R. Yamaguchi, Tetrahedron 64 (8), 1943–1954 (2008).

15. M.H Hamid et al., J. Am. Chem. Soc. 131 (5), 1766–1774 (2009).

16. T.E. Müller and M. Beller, Chem. Rev. 98 (2), 675–704 (1998).

17. M. Beller et al., Chem. Eur. J. 5 (4), 1306–1319 (1999).

18. M. Nobis and B. Driessen-Hölscher, Angew. Chem., Int. Ed. 40 (21), 3983–3985 (2001).

19. M. Utsunomiya et al., J. Am. Chem. Soc. 125 (19), 5608–5609 (2003).

20. J.S. Ryu, G.Y. Li, and T.J.J. Marks, J. Am. Chem. Soc. 125 (19), 12584–12605 (2003).

21. A.M. Johns et al., J. Am. Chem. Soc. 128 (6) 1828–1839 (2006).

22. D. Chan et al., Tetrahedron Lett. 39 (19), 2933–2936 (1998).

23. D.A. Evans, J.L. Katz, and T.R. West, Tetrahedron Lett. 39 (19) 2937–2940 (1998).

24. P.Y.S. Lam, et al., Tetrahedron Lett. 39 (19) 2941–2944 (1998).

25. P.Y.S. Lam et al., Synlett. 5, 674–676 (2000).

26. J.P. Collman and M. Zhong, Org. Lett. 2 (9), 1233–1236 (2000).

27. J.C. Antilla and S.L. Buchwald, Org. Lett. 3 (13), 2077–2079 (2001).

28. P.Y.S. Lam et al., Tetrahedron Lett. 42 (20), 3415–3453 (2001).

29. C. Moessner and C. Bolm, Org. Lett. 7 (13), 2667–2669 (2005).

30. J.B. Lan et al., Synlett. 6, 1095–1097 (2004).

31. B. Sreedhar et al., Synthesis 5, 795–799 (2008).

32. T. Tsuritaniet et al., Org. Lett. 10 (8), 1653–1665 (2008).

33. S. Bérnard, L. Neuville, and J. Zhu, J. Org. Chem. 73 (16) 6441–6444 (2008).

34. Boronic Acids, D.G. Hall, Ed., (1st Edition, Wiley-VCH, Weinheim, Germany, 2005).

35. I. González et al., Org. Lett. 11 (8) 1677–1680 (2009).

36. M. Larrosa et al., Synlett., 14, 2101–2105, (2010).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
25%
To select processes for both new and legacy products
20%
Do not use QbD
23%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here